Fatal pneumonia associated with adenovirus type 7 in three military trainees.

Adenoviruses in immunocompromised hosts. Clin Microbiol Rev (2008) 2.20

Severe adenovirus pneumonia in immunocompetent adults: a case report and review of the literature. Eur J Clin Microbiol Infect Dis (2008) 1.85

Analysis of 15 different genome types of adenovirus type 7 isolated on five continents. J Virol (1986) 1.69

Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine (2006) 1.59

Antibody-associated lymphotoxin in acute infection. J Clin Invest (1973) 1.34

Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J Biol Med (1975) 1.33

Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers. J Clin Microbiol (1975) 1.25

Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development. J Virol (2005) 1.24

Adenovirus-associated deaths in US military during postvaccination period, 1999-2010. Emerg Infect Dis (2012) 1.16

Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study. Crit Care (2014) 1.07

Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med (2011) 1.00

Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2. J Virol (2001) 0.92

Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery. Viruses (2010) 0.92

Outcomes of early administration of cidofovir in non-immunocompromised patients with severe adenovirus pneumonia. PLoS One (2015) 0.91

Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease. J Clin Microbiol (2005) 0.91

Human adenovirus type 7 infection associated with severe and fatal acute lower respiratory illness and nosocomial transmission. J Clin Microbiol (2014) 0.90

Evaluation of multiplex type-specific real-time PCR assays using the LightCycler and joint biological agent identification and diagnostic system platforms for detection and quantitation of adult human respiratory adenoviruses. J Clin Microbiol (2010) 0.89

Pneumonia in military trainees: a comparison study based on adenovirus serotype 14 infection. J Infect Dis (2011) 0.84

Lobar pneumonia associated with adenovirus type 7. Can Med Assoc J (1981) 0.78

Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. Thorax (1995) 0.77

Simian adenoviral pneumonia. Am J Pathol (1978) 0.77

Complete genome analysis of a novel E3-partial-deleted human adenovirus type 7 strain isolated in Southern China. Virol J (2011) 0.77

Arenavirus Diversity and Phylogeography of Mastomys natalensis Rodents, Nigeria. Emerg Infect Dis (2016) 0.76

Adenovirus Type 7 Pneumonia in Children Who Died from Measles-Associated Pneumonia, Hanoi, Vietnam, 2014. Emerg Infect Dis (2016) 0.76

Infectious diseases: annual review of significant publications. Postgrad Med J (1973) 0.75

Clinical Features and Radiological Findings of Adenovirus Pneumonia Associated with Progression to Acute Respiratory Distress Syndrome: A Single Center Study in 19 Adult Patients. Korean J Radiol (2016) 0.75

Severe community-acquired adenovirus pneumonia treated with oral ribavirin: a case report. BMC Res Notes (2017) 0.75

Respiratory viruses in patients with influenza-like illness in Senegal: Focus on human respiratory adenoviruses. PLoS One (2017) 0.75

Community-acquired adenovirus pneumonia in a patient with chronic lymphatic leukaemia. Eur J Clin Microbiol Infect Dis (2005) 0.75

Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child. J Infect Dis (1971) 2.83

The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64

M antigens among group A streptococci isolated from skin lesions. J Exp Med (1967) 2.35

Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT). An analysis of twenty cases of a peculiar sclerosing endothelial tumor. Cancer (1983) 2.34

Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med (1968) 1.95

Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95

Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88

Measles in Detroit, 1935 -I, Factors Influencing the Secondary Attack Rate Among Susceptibles at Risk. Am J Public Health Nations Health (1938) 1.86

A Small Outbreak of Smallpox in Detroit. Am J Public Health Nations Health (1943) 1.71

Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr Infect Dis J (1998) 1.63

Sclerosing hemangioma of the lung: a clinicopathologic study of 51 cases. Am J Surg Pathol (1980) 1.62

Ageusia as an adverse effect of phenytoin treatment. Lancet (1998) 1.59

Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44

The serum opacity reaction of Streptococcus pyogenes. The demonstration of multiple, strain-specific lipoproteinase antigens. J Exp Med (1968) 1.43

Human leptospirosis acquired from squirrels. N Engl J Med (1967) 1.42

Epidemiology of Poliomyelitis in Detroit in 1939. Am J Public Health Nations Health (1941) 1.40

Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39

Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38

Cells of Kultschitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor. Lab Invest (1967) 1.38

The serum opacity reaction of Streptococcus pyogenes: frequency of production of streptococcal lipoproteinase by strains of different serological types and the relationship of M protein production. J Hyg (Lond) (1968) 1.38

Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36

Ultrastructural identification of spirochetes and flagellated microbes at the brush border of the large intestinal epithelium of the rhesus monkey. Infect Immun (1972) 1.36

Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever. Am J Trop Med Hyg (1981) 1.36

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr (1998) 1.34

Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale J Biol Med (1975) 1.33

Korean hemorrhagic fever: propagation of the etiologic agent in a cell line of human origin. Science (1981) 1.33

Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33

The oto-palato-digital syndrome. A new symptom-complex consisting of deafness, dwarfism, cleft palate, characteristic facies, and a generalized bone dysplasia. Am J Dis Child (1967) 1.28

Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28

Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol (1973) 1.26

Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect Immun (1972) 1.21

The role of normal skin in the spread of streptococcal pyoderma. J Hyg (Lond) (1970) 1.18

Swine influenza A at Fort Dix, New Jersey (January-February 1976). II. Transmission and morbidity in units with cases. J Infect Dis (1977) 1.17

Pertussis agglutinins in adults. Public Health Rep (1969) 1.16

An epidemiologic study of hepatitis B virus in Bangkok, Thailand. Am J Epidemiol (1975) 1.13

Scanning electron microscopic observations on the surface of the normal and spirochete-infested colonic mucosa of the rhesus monkey. J Ultrastruct Res (1972) 1.11

Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat (2008) 1.10

Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group. Pediatr Infect Dis J (1998) 1.09

Specific and Nonspecific Serum Treatment of Scarlet Fever. Am J Public Health Nations Health (1939) 1.08

Serodiagnosis of hepatitis B virus infection by antibody to core antigen. J Infect Dis (1977) 1.07

Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses. J Infect Dis (1970) 1.02

Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med (1984) 1.02

Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol (1992) 1.01

Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. J Infect Dis (1979) 1.01

Hantaan virus, aetiological agent of Korean haemorrhagic fever, has Bunyaviridae-like morphology. Lancet (1982) 1.00

Role of arteriovenous shunts in venous reconstruction. Am J Surg (1971) 0.95

Serum antibodies reactant with Korean haemorrhagic fever agent in Scandinavian epidemic (endemic) nephropathy (nephropathia epidemica) demonstrated by immunofluorescence utilizing an in vitro antigen source. Scand J Infect Dis (1981) 0.93

Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers. Infect Immun (1972) 0.93

Subtypes of hepatitis B surface antigen in Southeast Asia. J Infect Dis (1975) 0.93

The pediatric clinic: diagnosing inefficiencies and measuring the effects of remedial action. Clin Pediatr (Phila) (1977) 0.92

Hepatitis B antigen in saliva, urine, and stool. Infect Immun (1975) 0.92

Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. J Infect Dis (1977) 0.91

Bone fragmentation in the rheumatoid wrist: radiographic and pathologic considerations. Radiology (1975) 0.91

Temperature-dependent variation in the synthesis of group-specific carbohydrate by streptococcal variant strains. I. Immunochemical studies. J Exp Med (1973) 0.91

Evaluation of the plasma kinin system in dengue hemorrhagic fever. J Lab Clin Med (1975) 0.89

Effect of saponins on the growth and activity of rhizosphere bacteria. Adv Exp Med Biol (1996) 0.88

The balanced scorecard in healthcare organizations: a performance measurement and strategic planning methodology. Hosp Top (2001) 0.88

Severe clinical expression in X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord (1999) 0.87

Dichotomy of antibody response to group A streptococcal antigens in Wiskott-Aldrich syndrome. J Lab Clin Med (1968) 0.86

Method for extracting viral hemagglutination-inhibiting antibodies from the nonspecific inhibitors of serum. Appl Microbiol (1970) 0.86

The effects of rate and route of nutrient intake on protein metabolism. J Surg Res (1986) 0.86

The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg (1975) 0.86

Adenovirus vaccines in military recruit populations: a cost-benefit analysis. J Infect Dis (1973) 0.85

Studies on Japanese B encephalitis virus vaccines from tissue culture. X. Characterization of a 37 degreeC passage line attenuated strain of OCT-541 virus. J Immunol (1969) 0.85

Kaeng Khoi virus from naturally infected bedbugs (cimicidae) and immature free-tailed bats. Bull World Health Organ (1976) 0.84

Structural polypeptides of Hazara virus. J Gen Virol (1981) 0.84

Coexistent trophoblastic tumor and viable pregnancy. Obstet Gynecol (1971) 0.84

Systemic artery to pulmonary vessel fistulas: report of two cases and a review of the literature. Chest (1972) 0.84

Host and tumor responses to increasing levels of intravenous nutritional support. Surgery (1983) 0.84

Postepidemic surveillance studies of a food-borne epidemic of streptococcal pharyngitis at the United States Air Force Academy. J Infect Dis (1969) 0.83

An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. Am J Epidemiol (1972) 0.83

Activated protein C resistance and acute ischaemic stroke: relation to stroke causation and age. J Neurol (2001) 0.83

Cephalexin and penicillin in the treatment of group A beta-hemolytic streptococcal throat infections. Am J Dis Child (1992) 0.83

Urinary fibrinopeptide A in evaluation of patients with suspected acute pulmonary embolism. A prospective pilot study. Chest (1991) 0.82

Scandinavian epidemic nephropathy and Korean haemorrhagic fever. Lancet (1980) 0.81

Persistence of antibody to hepatitis B surface antigen. J Clin Microbiol (1976) 0.81

Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. Bone Marrow Transplant (2000) 0.81

Multiple Antigens for Active Immunization : Report of the Study Committee on Multiple Antigens, Subcommittee on Evalution of Administrative Practices. Am J Public Health Nations Health (1944) 0.81

Differentiation of types 1 and 2 herpes simplex virus by plaque inhibition with sulfated polyanions. Proc Soc Exp Biol Med (1973) 0.80

Phenothiazine-induced lupus anticoagulant. J Clin Psychiatry (1992) 0.80

Herpes simplex virus type I from a patient with radiculoneuropathy. JAMA (1979) 0.80

Consultation in the coagulation laboratory. A conceptual analysis. Am J Clin Pathol (1981) 0.80

Host and tumor responses to varying rates of nitrogen infusion in the tumor-bearing rat. Ann Surg (1988) 0.80

Intracoronary artery thrombus formation in unstable angina: a clinical, biochemical and angiographic correlation. J Am Coll Cardiol (1993) 0.79

Elevated plasmz zinc: a heritable anomaly. Science (1976) 0.79

Basilar artery blood flow during head rotation in vertebrobasilar ischemia. Acta Neurol Scand (1996) 0.78

Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull (1995) 0.78

Prophylaxis against respiratory syncytial virus in premature infants. IMpact-RSV Study Group. Lancet (2000) 0.78

Influence of total nitrogen, asparagine, and glutamine on MCA tumor growth in the Fischer 344 rat. Surgery (1988) 0.78

Streptococcal group A carbohydrate antibody in rheumatic and nonrheumatic bacterial endocarditis. J Lab Clin Med (1970) 0.77

Urinary fibrinopeptide A levels in ischemic heart disease. J Am Coll Cardiol (1989) 0.77

Nearly identical oral and intravenous nutritional support in the rat: effects on growth and body composition. Am J Clin Nutr (1984) 0.77

Epidemic disease in Hong Kong, 1968, associated with an antigenic variant of Asian influenza virus. Am J Public Health Nations Health (1970) 0.77

Gonococcal infections in young children. Studies on the social, familial, and clinical aspects of 11 instances. Clin Pediatr (Phila) (1977) 0.77